期刊文献+

利用MALDI-TOFMS进行恶性肿瘤血清蛋白组学研究方法的建立 被引量:1

Establishment of standard methods in cancer serum proteomics research with MALDI-TOF MS
下载PDF
导出
摘要 目的:建立一套稳定的利用MALDI-TOF MS进行恶性肿瘤血清蛋白质组学分析方法。方法:通过对血清样品采集、保存条件的优化,标准蛋白质的选择,样品的前处理和上样分析等多种条件的优化,确定各个相关参数的选择。结果:经实验条件的比较与优化发现,血液样本采集1 h后经2000 g离心分离血清,分装成若干份,冻存于-80℃冰箱备用,样本前处理方法参照说明书进行;质谱分析条件为应用线性模式,采集范围800-10,000Da,利用多点采集的方法,8点采集,累加至400shots,保存备用。结论:通过优化实验条件,初步建立了利用MALDI-TOF MS进行血清蛋白质组学分析的一整套研究方法,生物质谱分析结果的整体稳定性和重复性可满足统计学和临床医学实验室分析要求。 Objective:To establish standard methods to study cancer serum proteomics with MALDI-TOF MS.Methods:We optimized the selection of blood collection tubes,the serum samples collection,conservation condition,pre-extraction procedure,standard protein and peptides chosen and MALDI-TOF MS reference parameters setting.Results:The best conservation condition was to put numbers on the tubes at first,then clotting at least one hour before centrifugation and put to-80℃ for up to a year,using microflex MS,linear mode,mass range 800-10,000Da,accumulate 8 spots and add up to 400shots to save.Conclusion:By optimizion,established standard methods used in biochemistry laboratory,the mass spectrometry analysis shows that the stability and reproducibility is good to meet the statistical analysis and clinical medicine laboratory requirements.So we can do more samples analysis by using these methods,and the proteomics information is stable and reproductive.
出处 《中国卫生检验杂志》 CAS 2008年第12期2477-2479,2521,共4页 Chinese Journal of Health Laboratory Technology
关键词 血清蛋白质组学 MALDI-TOFMS 标准方法 Serum proteomics standard method MALDI-TOF MS Methodology
  • 相关文献

参考文献12

  • 1Conrads TP, Hood BL, Issaq HJ, et al. Proteomic patterns as a diagnostic tool for early - stage cancer:a review of its progress to a clinically relevant tool[J]. Mol Diagn, 2004,8(2) :77 -85.
  • 2Posadas EM, Davidson B, Kohn EC. Proteomics and ovarian cancer: implications for diagnosis and treatment : a critical review the recent literature[ J]. Curr Opin Oncol,2004,16(5 ) :478 -484.
  • 3利布来尔.蛋白质组学导论[M].北京:科学出版社,2005:163.
  • 4Chambers G, Lawrie L,Cash P, et al. Proteomics: a new approach to the study of disease [ J ]. J Pathol, 2000,192:280 - 288.
  • 5Banks RE, Dunn MJ, Hochstrasser DF, et al. Proteomics:new perspectives, new biomedical opportunities [ J ]. Lancet, 2000, 356 : 1749 - 1756.
  • 6ALAOUI-JAMALI Moulay A..Review:Proteomic technology for biomarker profiling in cancer: an update[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2006,7(6):411-420. 被引量:9
  • 7Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects [ J ]. Mol Cell Proteomics, 2002, 1 ( 11 ) :845 -867.
  • 8Liotta LA, Ferrari M, Petricoin E. Clinical proteomles :Written in blood [ J]. Nature,2003,425 (6961) :905.
  • 9Srinivas PR,Kramer BS,Sfivastava S. Trends in biomarker research for cancer detection[ J]. Lancet Onco1,2001,2( 11 ) :689 - 704.
  • 10Petreoin EF,Ardekani AM, Hitt BA,et al. Use of proteomic patterns in - rlm to identify ovarian cancer[ J ]. Lancet,2002,359 (9306) :572 - 577.

共引文献8

同被引文献13

  • 1吴红金,马增春,高月,王升启.蛋白质组学技术对冠心病血瘀证相关蛋白的研究[J].中西医结合心脑血管病杂志,2005,3(3):189-191. 被引量:56
  • 2贺石林,葛金文.正确选择血标本的思考[J].诊断学理论与实践,2005,4(6):433-434. 被引量:7
  • 3Zhang X,Leung SM ,Morris CR ,et al. Evaluation of a novel , integrated approach using functionalized magnetic beads , benchtop MALDI-TOF-MS with prestructured sample supports , and pattern recognition software for profiling potential biomarkers in human plasma [ J] . J Biomol Tech,2004,15 : 167-175.
  • 4Sven B, Uta C, Georg MF, et al. Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ ionization time of flight mass spectrometry [ J ]. Clin Chem,2005,6:51.
  • 5Thadikkaran L, Siegenthaler M A, Crettaz D, et al. Recent advances in blood-related proteomics [ J]. Proteomics 2005, 5 ( 1 ) :3019-3034.
  • 6Tammen H, Schuhe I, Hess R, et al. Peptidomics analysis of human blool specimens: comparison between plasma specimens and serum by differential peptide display [ J ]. Proteomics.. 2005,5 ( 13 ) :3414-3422.
  • 7Tammen H, Peck A, Budde P, et al. Peptidomics analysis of human blood specimens for biomarkers discovery[J]. Expert Rev Mol Diagn ,2007,7(5) :605-613.
  • 8Cheng A J, Chen LC, Chien KY,et al. Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology [ J ]. Clin Chem,2005 ,51:2236-2244.
  • 9Villanuera J, Philip J, Entenberg D, et al. Serum peptide profiling by magnetic Particle assisted, automated sample processing and MALDI-TOF mass spectrometry [J]. Anal Chem, 2004,76 : 1560-1570.
  • 10王剑,刘殿武,曹国玉.基于磁珠处理的MALDI-TOF实验技术优化[J].河北北方学院学报(医学版),2008,25(5):1-4. 被引量:2

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部